| Evaluating anti-calcitonin gene-related peptide monoclonal antibodies on long-term real-world treatment is of paramount importance. |
| Monthly fremanezumab showed effectiveness and tolerability in patients with drug-resistant severe migraine over 54 weeks of treatment. |
| Further studies specifically designed to evaluate a multi-assessed late response are needed. |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.